Arkolith/Insider Trading/SYRE/Form 4

Turtle Cameron

Chief Executive Officer, DirectorSpyre Therapeutics, Inc. (SYRE) · full profile →Form 4 · filed Mar 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$633K
Net Open-Market Flow
-$633K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)9K$42.49$387K643K
Mar 2, 2026Sell(S)6K$41.73$246K652K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001636282-26-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML